Zhejiang Wecome Pharmaceutical Company Limited (300878.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap3.62B
Enterprise Value3.66B
P/E Ratio-23.05
PEG Ratio0.6
Price/Sales Ratio21.78
Price/Book Ratio5.38
Enterprise/Revenue22.04
Enterprise/EBITDA-34.41

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.96
Operating Margin-0.81
AD

Management Effectiveness

Return On Assets-0.17
Return On Equity-0.22

Income Statement

Revenue225.06M
Revenue/Share1.59
Gross Profit48.22M
EBITDA-138.2M
Net Income-227.34M
Diluted EPS-1.6

Balance Sheet

Total Cash191.9M
Total Cash/Share1.35
Total Debt239.58M
Total Debt/Equity0.26
Current Ratio1.95
Book Value Per Share6.52

Price History

52-Week Change103.78
52-Week High40.22
52-Week Low16.3
Moving Average 50 Days32.06
Moving Average 200 Days28.17

Statistics

Average Volume4.16M
Shares Outstanding142.05M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.12
Last Split Factor9:5
Last Split DateJune 17, 2022
AD